Signal-averaged ECG in patients after anthracycline therapy for childhood cancer

Neoplasma

Volumn 45, Issue 1, 1998, Pages 40-45

  Mladosievicova B ^a   Foltinova A ^b   Bernadic M ^a   Hubka, P ^a   Petrasova H ^a   Hulin I ^a  

^a Physics and Informatics   (Slovakia)

^b University Children's Hospital Bratislava   (Slovakia)

Author keywords

Anthracycline cardiotoxicity; Children; Frequency domain analysis; Late potentials

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CARDIOTOXICITY; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HEART MUSCLE POTENTIAL; HUMAN; MALE; PROGNOSIS; SCHOOL CHILD; SIGNAL AVERAGED ELECTROCARDIOGRAPHY;

EID: 0031972186     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. BILLINGHAM, M.E., MASON, G.W., BRISTOW, M.R., DANIELS, J.R.: Anthracycline cardiomyopathy monitored by morphological changes. Cancer Treat. Rep., 62, 1978, 865-872.
2. BU'LOCK, A. F., MOTT, M.G., OAKHILL, A., MARTIN, R.P.: Left ventricular diastolic function after anthracycline chemotherapy in childhood: Relation with systolic function, symptoms, and pathophysiology. Br. Heart J., 73, 1995, 340-350.
3. BU'LOCK, F.A., GABRIEL, H.M., OAKHILL, A., MOTT, M.G., MARTIN, R.P.: Cardioprotection by ICRF 187 against high dose anthracycline cardiotoxicity in children with malignant disease. Br. Heart J., 70, 1993, 185-188.
4. CAIN, M.E., ANDERSON, J.L., ARNSDORF, M.F., MASON J., W., SCHEINMAN, M.M., WALDO, A.L.: Signal-averaged electrocardiography. J. Am. Coll. Cardiol., 27, 1996, 238-249.
5. DAVIS, L.E., BROWN, C.E.: Periparmm heart failure in a patient treated previously with doxorubicin. Obstet. Gynecol., 71, 1988, 506-508.
6. DUNBAR, D.N., DENES, P.: Operational aspects of signal-averaged electrocardiography. Progress Cardiovasc. Dis., 35, 1993, 329-348.
7. EL SHERIF,N., MEHRA, R., GOMES, J.A.C., KELEN, G.: Appraisal of a low noise electrocardiogram. J. Am. Coll. Cardiol., 1, 1983, 456-467.
8. GANZ, W.I., STRIDHAR, K.S., GANZ, S.S., GONZALES,R., CHAKKO, S., SERAFINI, A.: Review of tests for monitoring doxorubocin-induced cardiomyopathy. Oncology, 53, 1996, 461-470.
9. GOORIN, A.M., CHAUVENET, A.R., PEREZ-ATAYDE, A.R., CRUZ, J., MCKONE, R., LIPSHULTZ, S.E.: Initial congestive heart failure six to ten years after doxorubicin chemotherapy for childhood cancer. J Pediat., 116, 1990, 143-147.
10. HABERL, R., WEBER, M., REICHENSPURNER, H., KEMKES, B.M., OSTERHOLZER G., ANTHUBER, M., STEINBECK, G.: Frequency analysis of the surface electrocardiogram for recognition of acute rejection after orthotopic cardiac transplantation in men. Circulation, 76, 1987, 101-108.
11. HALE, J.P., LEWIS, I.J.: Anthracyclines: Cardiotoxicity and its prevention. Arch. Dis. Childhood, 71, 1994, 457-462.
12. HOOD, M.A., POGWIDZ, S.M., PEIRICK, J., CAIN, M.E.: Contribution of myocardium responsible for ventricular tachycardia to abnormalities detected by analysis of signal-averaged ECGs. Circulation, 86, 1992, 1888-1901.
13. HRUSHESKY, W.J. M.., FADER, D.J., BERESTKA, J.S., SOMMER, M., HAYES, J., COPE, F.O.: Diminishment of respiratory sinus arrhythmia foreshadows doxorubicin-induced cardiomyopathy. Circulation, 84, 1991, 697-707.
14. HULIN, I., SLAVKOVSKY, P., HATALA, R., PETRASOVA, H., CIK, V., MURIN, J.: Gliding window fast Fourier transform analysis. A new method for discovering the contribution of higher frequencies in signal-averaged ECG. Can. J. Cardiol., 9, 1993, 789-796.
15. JAKACKI, R.I., LARSEN, L.R., BARBER, G., HEYMAN, S, FRIDMAN, M., SILBER, J.H.: Comparison of cardiac function tests after anthracycline therapy in childhood. Cancer, 72, 1993, 2739-2745.
16. KEELING, P.J., KULAKOWSKI, P., YI, G., SLADE, A.K.B., BENT, S.E., MCKENNA, W. J.: Usefulness of signal-averaged electrocardiogram in dilated cardiomyopathy for identifying patients with ventricular arrhythmias. Am. J. Cardiol., 72, 1993, 78-84.
17. KINOSHITA, O., FONTAINE, G., ROSAS, F., ELIAS, J., IWA, T., TONET, J., LASCAUT, G., FRANK, R.: Time- and frequency-domain analyses of the signal-averaged ECG in patients with arrhythmogenic right ventricular dysplasia. Circulation, 91, 1995, 715-721.
18. KVĚTINA, J., GROSSMANN, V., SVOBODA, Z., ŠAFÁŘOVá, M.: Preclinical comparison of bis-diketopiperazine-propane (dexrazoxane) and bis-diketopiperazine-ethane (antimet) on the adriamycin-cardiotoxic effect. Neoplasma, 44, 1997, 97-99.
19. LEONARDIS, V., BARTALUCCI, S., CINELLI, P., DE SCALZI, M.,BECUCCI, A., LOTTINI, G., NERI, B.: Ventricular late potentials in the assessment of mitoxantrone cardiotoxicity. Cardiology, 79, 1991, 110-115.
20. LIPSHULTZ, S.E., COLAN, S.D., GELBER, R.D., PEREZ-ATAYDE, A.K., SALLAN, S.E., SANDERS, S.P.: Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. New Engl. J. Med., 324, 1991,808-815.
21. MANCINI, D.M., WONG, K.L., SIMSON, M.B.: Prognostic value of abnormal signal-averaged electrocardiogram in patients with nonischemic congestive cardiomyopathy. Circulation, 87, 1993, 1083-1092.
22. MCKILLOP, J.H., BRISTOW, M.R., GORIS, M.L.: Sensitivity and specifity of radionuclide ejection fractions in doxorubicin cardiotoxicity. Am. Heart J., 106, 1983, 1048-1056.
23. NOVAK, P., ZHIXING, L., NOVAK, V., HATALA, R.: Time-frequency mapping of the QRS complex in normal subjects and in postmyocardial infarction patients. J. Electrocardiol., 27, 1994, 49-60.
24. POSTMA, A., BINK-BOELKENS, M.T.E., BEAUFORT-KROL, G.C.M., KENGEN, R.A.M., ELZENGA, N.J., SCHASFOORT-VAN LEEUWEN, M.J.M., SCHRAFFORDT KOOPS, H., KAMPS, W.A.: Late cardiotoxicity after treatment for a malignant bone tumor. Med. Ped. Oncol., 26, 1996, 230-237.
25. SILVERMAN, M.E., PRESSEL, M.D., BRACKETT, J.C., LAURIA, S.S., GOLD, M.R., GOTTLIEB, S.S.: Prognostic value of the signal-averaged electrocardiogram and a prolonged QRS in ischemic and nonischemic cardiomyopathy. Am. J. Cardiol., 75, 1995, 460-464.
26. SIMSON, M.B.: Use of signals in the terminal QRS complex to identify patients with ventricular tachycardia after myocardial infarction. Circulation, 64, 1981, 235-246.
27. STEINHERZ, L.J.: Anthracycline cardiomyopathy - a growing clinical concern. In: Proceedings from Satellite Symposium during the 28th International Society of Paediatric Oncology Meeting, Vienna, Austria, 1996, 8-9.
28. STEINHERZ, L.J., STEINHERZ, P.G., TAN, CH.: Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: A series of 15 patients. Med. Ped. Oncol., 24, 1995,352-361.
29. STEINHERZ, L.J., STEINHERZ, P.G.,TAN, CH.T.C.,HELLER, G., MURPHY, L.: Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA, 266, 1991, 1672-1677.
30. TAMMINGA, R.Y.J., BINC-BOELKENS, M.TH.E., KIEVIT, J.: Ventricular late potentials: Another expression of cardiotoxicity of cytostatic drugs in children? Int. J. Cardiol., 36, 1992, 283-288.
31. WEBER, M., HABERL, R., REITH, R., LUCHNER, A., SCHUTZ, A., KEMKES, B., STEINBECK, G.: Fourier analysis of the surface electrocardiogram: A new noninvasive method to detect acute rejection after orthotopic heart transplantation in humans. Transpl. Proc., 22, 1990, 1460-1461.
32. WEISS, R.B.: The anthracyclines: Will we ever find a better doxorubicine? Semin Oncol., 19, 1992, 670-686.
33. YI, G., KEELING, P.J., GOLDMAN, J.H., JIAN, H., POLONIECKI, J., MCKENNA, W.J.: Prognostic significance of spectral turbulence analysis of the signal-averaged electrocardiogram in patients with idiopathic dilated cardiomyopathy. Am. J. Cardiol., 75, 1995, 494-497.